mortality/aging
|
• all mice survive DSS treatment unlike similarly treated wild-type mice
|
immune system
|
• DSS-treated mice exhibit reduced and delayed clinical symptoms of colitis, increased cell proliferation in the colon, delayed leukocyte infiltration into the lamina propria, and delayed cytokine expression (IL6, MCP1, IFN-gamma, TNFalpha, and IL10) compared with similarly treated wild-type mice
• all mice survive DSS treatment unlike similarly treated wild-type mice
|
|
• in DSS-treated mice
|
|
• in DSS-treated mice
|
|
• in DSS-treated mice
|
|
• in DSS-treated mice
|
homeostasis/metabolism
|
• all mice survive DSS treatment unlike similarly treated wild-type mice
|
digestive/alimentary system
|
• DSS-treated mice exhibit reduced and delayed clinical symptoms of colitis, increased cell proliferation in the colon, delayed leukocyte infiltration into the lamina propria, and delayed cytokine expression (IL6, MCP1, IFN-gamma, TNFalpha, and IL10) compared with similarly treated wild-type mice
• all mice survive DSS treatment unlike similarly treated wild-type mice
|


Analysis Tools